Avalo Therapeutics (AVTX) Intangibles (2017 - 2021)
Avalo Therapeutics (AVTX) reported Intangibles of $38,000 for Q4 2021, down 97.6% from $1.59 million a year earlier and down 87.5% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Intangibles (2017 - 2021) Analysis & Trends
Dating back to Q4 2017, Avalo Therapeutics' Intangibles record includes 17 quarters.
- Intangibles has declined for four consecutive years, with a four-year compound annual growth rate of -78.5% (FY2017 to FY2021).
- By year, Intangibles came in at $1.59 million in FY2020 (-34.7%), $2.43 million in FY2019 (-35.6%), $3.77 million in FY2018 (-78.7%) and $17.66 million in FY2017.
- The Q4 2021 figure ranks as the lowest quarterly Intangibles in data going back to Q4 2017.
- Year over year, Intangibles has now declined in each of the last 13 quarters, with an average decline of 77.1% over the last eight quarters.
- Over the past five years, the year-over-year decline in Intangibles ranged from 8.9% (Q1 2019) to 97.6% (Q4 2021).
- Per Business Quant data, the three quarters before Q4 2021 came in at $304,000 (Q3 2021), $732,000 (Q2 2021) and $1.16 million (Q1 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Avalo Therapeutics | 533.82 Mn | -158.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 304,000.00 |
| Jun 30, 2021 | 732,000.00 |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.89 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Mar 31, 2020 | 2.70 Mn |
| Dec 31, 2019 | 2.43 Mn |
| Sep 30, 2019 | 26.60 Mn |
| Jun 30, 2019 | 27.63 Mn |
| Mar 31, 2019 | 30.16 Mn |
| Dec 31, 2018 | 3.77 Mn |
| Sep 30, 2018 | 32.46 Mn |
| Jun 30, 2018 | 32.00 Mn |
| Mar 31, 2018 | 33.10 Mn |
| Dec 31, 2017 | 17.66 Mn |
API Access
Avalo Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();